Prediction Case File
YouTubeEvaluation Complete

CARDANO ADA PRICE PREDICTION 2025

1 extracted signal · 1 resolved · 0 still active

Cilinix Crypto profile imageCilinix Crypto24 Nov 2025, 15:46 UTC
Video preview for CARDANO ADA PRICE PREDICTION 2025
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
0
Canonical correct result
Failed
1
Canonical failed result
Resolved success
0%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analysis focuses on Cardano (ADAUSDT) using a 3-day chart. The current price is approximately $0.44. The analyst anticipates a short-term bearish trend, potentially reaching a support level between $0.38 and $0.355. A mechanical bounce is expected from this level, with a potential target of $0.54, maybe even $0.62, serving as intraday support level. The analysis infers a failure level at $0.37, The presenter combines point of control, trend line, the last fair value gap and chart patterns to infer short term trend.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

Cilinix Crypto

Tracked signals
1195
Historical success
42.8%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.